logo image
search icon
Global Digital Diabetes Management Market

Digital Diabetes Management Market Size, Share & Trends Analysis Report By Product and Services (Devices, Application, Data management software and platforms, services), By Type, By End-User, By Region, And Segment Forecasts, 2024-2031

Report ID : 1487 | Published : 2024-05-22 | Pages: 180 | Format: PDF/EXCEL

The Global Digital Diabetes Management Market Size is valued at USD 18.11 billion in 2023 and is predicted to reach USD 49.48 billion by the year 2031 at an 13.58% CAGR during the forecast period for 2024-2031.

Key Industry Insights & Findings from the Report:

  • New digital apps that use augmented and virtual reality to monitor blood glucose levels are driving the growth of the digital diabetes management industry.
  • The increasing prevalence of diabetes has magnified the importance of the demand for improved diabetes care solutions.
  • North America dominated the market and accounted for a revenue share of global revenue in 2023.
  • The industry is expected to be constrained by a lack of knowledge about digital diabetes treatment in developing nations.

digital diabetes management

A collection of programs known as diabetes management software can assist patients and healthcare professionals track and monitor their diabetes. Diabetes management software is gaining popularity for various applications in the healthcare sector thanks to its multiple mobile and desktop apps, propelling growth in the diabetes management software market. To measure, monitor, and manage the degree of diabetes, diabetes management software is available for use on personal computers, mobile phones, tablets, and other digital assistants.

The market is expanding due to the adoption of diabetes awareness programs and other measures by various governments. These businesses' media efforts and initiatives for treating and preventing diabetes aid in raising public knowledge of the presence of multiple technologies in this industry. Diabetic patients have a high need for continuous blood glucose monitoring, which will significantly impact the growth of the global market over the forecast period. The market is estimated to face challenges in the future due to the growth in data security concerns and lower penetration in developing countries.

As there was a high risk of contracting COVID, the market for digital technologies for disease management among diabetes patients was growing. The product was created and planned to give patients a customized insight into how their blood sugar levels will respond to their diet, insulin dosage, and daily schedule. Therefore, the adoption and accessibility of such cutting-edge, rising, and unique technologies in the field of digital diabetes management would enhance market growth during the projection period.

Competitive Landscape

Some major key players in the Global Digital Diabetes Management Market:

  • Medteronic (Ireland),
  • Melsungen AG (Germany),
  • Dexcom, Inc. (US),
  • Abbott Laboratories (US),
  • Hoffmann-La Roche (Switzerland),
  • Insulet Corporation (US),
  • Tandem Diabetes (US),
  • Ascensia Diabetes Care Holdings AG (Switzerland)
  • LifeScan Inc. (US)
  • Tidepool (US),
  • AGaMatrix (US),
  • Glooko, Inc. (US),
  • DarioHealth Coporation (Israel),
  • One Drop (US),
  • Dottli (Finland),
  • Ypsomed Holding AG (Switzerland)
  • ARKRAY (Japan),
  • ACON Laboratories, Inc. (US),
  • Care Innovaions, LLC (US),
  • Health2Sync (Taiwan),
  • Emperra GmbH E-Health Technologies (Germany),
  • Azumio (US),
  • Decide Clinical Software GmbH (Germnay)
  • BeatO (India)

Market Segmentation:

The digital diabetes management market is divided into product & service, application, device type and end-use. Based on products & services, the market is segmented into devices (smart glucose meters, continuous glucose monitoring systems, and smart insulin pens, smart insulin pumps/ closed-loop pumps & smart insulin patches), application (diabetes & blood glucose tracking apps, obesity & diet management apps), data management software & platforms and services. The digital diabetes management market is segmented based on the device type into handheld and wearable devices. Based on end-use, the digital diabetes management market is divided into self/home healthcare, hospitals & speciality diabetes clinics and academic & research institutes.

Based on end users, the self/home healthcare segment is a major contributor to the digital diabetes management market.

The market's leading segment is self/home healthcare. The devices available on the market have an intuitive user interface coupled with cutting-edge digital gadgets. Adoption of these devices is becoming more necessary as patient awareness of diabetes management rises. This market is anticipated to grow due to the devices' use in exchanging crucial information with professionals via digital platforms. The market is anticipated to become less active due to widespread access to professionals in home healthcare. Due to the conditions, there was a high demand for digital diabetes management tools in the home settings market during the pandemic. During the pandemic, this sector received a significant boost from people using mobile applications and other connected devices at home.

The continuous glucose monitoring segment witnessed growth at a rapid rate.

Continuous glucose monitoring grabbed the highest revenue share, and it is anticipated that they will continue to hold that position during the anticipated time due to factors including ongoing technological development, rising product launches, greater incorporation of remote monitoring technologies into devices, rising availability of these gadgets, and increasing public awareness. Abbott established a freestyle libre system by enhancing its services in this industry. The use of this device will assist in tracking a patient's real-time blood glucose readings. Additionally, it gives a thorough picture of each person's glucose levels.

The North American digital diabetes management market holds a significant regional revenue share.

The North American digital diabetes management market is expected to register the highest market share. Numerous reasons, including the emphasis on ongoing technical breakthroughs, impending product launches with cutting-edge features, and the presence of significant market players in the North American region, have contributed to this region's success. The region's rising diabetic patient population provides growth prospects for the key market participants. Additionally, Asia Pacific is anticipated to increase quickly in the coming years. This market is expected to grow due to various factors, including an increase in the number of individuals with diabetes, growing healthcare costs, and an increasing number of market competitors in the area. It is also anticipated that rising disposable income and increased public knowledge of diabetes and other related health issues will promote the development of this industry.

Recent Developments:

  • In May 2024, Dexcom has introduced the Dexcom ONE+ continuous glucose monitor (CGM) in the UK. ONE+ utilized Dexcom's preexisting sensor design, adding input from users and healthcare experts during the development process. The organization affirmed that this guaranteeed a user-friendly and exceptionally efficient continuous glucose monitoring (CGM) experience for individuals managing type 2 or type 1 diabetes with insulin.

 

Global Digital Diabetes Management Market Report Scope

Report Attribute

Specifications

Market Size Value In 2023

USD 18.11 billion

Revenue Forecast In 2031

USD 49.48 billion

Growth Rate CAGR

CAGR of 13.58% from 2024 to 2031

Quantitative Units

Representation of revenue in US$ Billion and CAGR from 2024 to 2031

Historic Year

2019 to 2023

Forecast Year

2024-2031

Report Coverage

The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends

Segments Covered

Product and services, Type, End-User

Regional Scope

North America; Europe; Asia Pacific; Latin America; Middle East & Africa

Country Scope

U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia

Competitive Landscape

Medteronic (Ireland), B.Melsungen AG (Germany), Dexcom, Inc. (US), Abbott Laboratories (US), F. Hoffmann-La Roche (Switzerland), Insulet Corporation (US), Tandem Diabetes (US), Ascensia Diabetes Care Holdings AG (Switzerland) LifeScan Inc. (US) Tidepool (US), AGaMatrix (US), Glooko, Inc. (US), DarioHealth Coporation (Israel), One Drop (US), Dottli (Finland), Ypsomed Holding AG (Switzerland) ARKRAY (Japan), ACON Laboratories, Inc. (US), Care Innovaions, LLC (US), Health2Sync (Taiwan), Emperra GmbH E-Health Technologies (Germany), Azumio (US), Decide Clinical Software GmbH (Germnay) and BeatO (India) among others

Customization Scope

Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape.

Pricing And Available Payment Methods

Explore pricing alternatives that are customized to your particular study requirements.

Chapter 1. Methodology and Scope

1.1. Research Methodology

1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Digital Diabetes Management Market Snapshot

Chapter 4. Global Digital Diabetes Management Market Variables, Trends & Scope

4.1. Market Segmentation & Scope

4.2. Drivers

4.3. Challenges

4.4. Trends

4.5. Investment and Funding Analysis

4.6. Industry Analysis – Porter’s Five Forces Analysis

4.7. Competitive Landscape & Market Share Analysis

4.8. Impact of Covid-19 Analysis

Chapter 5. Market Segmentation 1: by Product & Services Estimates & Trend Analysis

5.1. by Product & Services & Market Share, 2019 & 2031

5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Product & Services:

5.2.1. Devices

5.2.1.1. Smart Glucose Meters

5.2.1.2. Continuous Glucose Monitoring (CGM) Systems

5.2.1.3. Smart Insulin Pens

5.2.1.4. Smart Insulin Pumps/Closed-loop Pumps & Smart Insulin Patches

5.2.2. Application

5.2.2.1. Diabetes & Blood Glucose Tracking Apps

5.2.2.2. Obesity & Diet Management Apps

5.2.3. Data Management Software & Platforms

5.2.4. Services

Chapter 6. Market Segmentation 2: by Device Type Estimates & Trend Analysis

6.1. by Device Type & Market Share, 2019 & 2031

6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Device Type:

6.2.1. Handheld Devices

6.2.2. Wearable Devices

Chapter 7. Market Segmentation 3: by End-user Estimates & Trend Analysis

7.1. by End-user & Market Share, 2019 & 2031

7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by End-user:

7.2.1. Self/ Home Healthcare

7.2.2. Hospitals & Specialty Diabetes Clinics

7.2.3. Academic & Research Institutes

Chapter 8. Digital Diabetes Management Market Segmentation 4: Regional Estimates & Trend Analysis

8.1. North America

8.1.1. North America Digital Diabetes Management Market Revenue (US$ Million) Estimates and Forecasts by Product & Services, 2024-2031

8.1.2. North America Digital Diabetes Management Market Revenue (US$ Million) Estimates and Forecasts by Device Type, 2024-2031

8.1.3. North America Digital Diabetes Management Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2024-2031

8.1.4. North America Digital Diabetes Management Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031

8.2. Europe

8.2.1. Europe Digital Diabetes Management Market Revenue (US$ Million) Estimates and Forecasts by Product & Services, 2024-2031

8.2.2. Europe Digital Diabetes Management Market Revenue (US$ Million) Estimates and Forecasts by Device Type, 2024-2031

8.2.3. Europe Digital Diabetes Management Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2024-2031

8.2.4. Europe Digital Diabetes Management Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031

8.3. Asia Pacific

8.3.1. Asia Pacific Digital Diabetes Management Market Revenue (US$ Million) Estimates and Forecasts by Product & Services, 2024-2031

8.3.2. Asia Pacific Digital Diabetes Management Market Revenue (US$ Million) Estimates and Forecasts by Device Type, 2024-2031

8.3.3. Asia-Pacific Digital Diabetes Management Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2024-2031

8.3.4. Asia Pacific Digital Diabetes Management Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031

8.4. Latin America

8.4.1. Latin America Digital Diabetes Management Market Revenue (US$ Million) Estimates and Forecasts by Product & Services, 2024-2031

8.4.2. Latin America Digital Diabetes Management Market Revenue (US$ Million) Estimates and Forecasts by Device Type, 2024-2031

8.4.3. Latin America Digital Diabetes Management Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2024-2031

8.4.4. Latin America Digital Diabetes Management Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031

8.5. Middle East & Africa

8.5.1. Middle East & Africa Digital Diabetes Management Market Revenue (US$ Million) Estimates and Forecasts by Product & Services, 2024-2031

8.5.2. Middle East & Africa Digital Diabetes Management Market Revenue (US$ Million) Estimates and Forecasts by Device Type, 2024-2031

8.5.3. Middle East & Africa Digital Diabetes Management Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2024-2031

8.5.4. Middle East & Africa Digital Diabetes Management Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031

Chapter 9. Competitive Landscape

9.1. Major Mergers and Acquisitions/Strategic Alliances

9.2. Company Profiles

9.2.1. Medteronic (Ireland)

9.2.2. B.Melsungen AG (Germany)

9.2.3. Dexcom, Inc. (US)

9.2.4. Abbott Laboratories (US)

9.2.5. F. Hoffmann-La Roche (Switzerland)

9.2.6. Insulet Corporation (US)

9.2.7. Tandem Diabetes (US)

9.2.8. Ascensia Diabetes Care Holdings AG (Switzerland) LifeScan Inc. (US)

9.2.9. Tidepool (US)

9.2.10. AGaMatrix (US)

9.2.11. Glooko, Inc. (US),

9.2.12. DarioHealth Coporation (Israel)

9.2.13. One Drop (US)

9.2.14. Dottli (Finland)

9.2.15. Ypsomed Holding AG (Switzerland)

9.2.16. ARKRAY (Japan)

9.2.17. ACON Laboratories, Inc. (US)

9.2.18. Care Innovaions, LLC (US)

9.2.19. Health2Sync (Taiwan)

9.2.20. Emperra GmbH E-Health Technologies (Germany)

9.2.21. Azumio (US)

9.2.22. Decide Clinical Software GmbH (Germnay)

9.2.23. BeatO (India)

9.2.24. Other Prominent Players

 

Segmentation of Digital Diabetes Management

By Product & Services

  • Devices
    • Smart Glucose Meters
    • Continuous Glucose Monitoring (CGM) Systems
    • Smart Insulin Pens
    • Smart Insulin Pumps/Closed-loop Pumps & Smart Insulin Patches
  • Application
    • Diabetes & Blood Glucose Tracking Apps
    • Obesity & Diet Management Apps
  • Data Management Software & Platforms
  • Services

Digital Diabetes Management Market

By Device Type

  • Handheld Devices
  • Wearable Devices

By End User

  • Self/ Home Healthcare
  • Hospitals & Specialty Diabetes Clinics
  • Academic & Research Instuties

By Region-

North America-

  • The US
  • Canada
  • Mexico

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • South East Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa

InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.

user icon
office icon
mail icon
call icon

This website is secure, and we do not share your personal information with any third party. Privacy Policy

Need Customization
Need specific information/chapter from the report of the custom data table, graph or complete report? Tell us more.

Frequently Asked Questions

How big is the Digital Diabetes Management Market?

The Global Digital Diabetes Management Market is expected to grow at an 13.58% CAGR during the forecast period for 2024-2031.

Medteronic (Ireland), B.Melsungen AG (Germany), Dexcom, Inc. (US), Abbott Laboratories (US), F. Hoffmann-La Roche (Switzerland), Others

Our Clients

  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo

Media Citations

  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo

Growth opportunities and latent adjacency in Healthcare IT

Select Licence Type
$4456
$7786
$10000
$1200
Get Your GTM Strategy

Navigate market entry with channel selection, launch strategy & timeline, and pricing model support.

Equip yourself with the insights needed to develop a winning go-to-market strategy

Get real-time updates and joint control over project direction with our collaborative approach